VOIXNOSIS
LIVE

Serial Number

97743897

Owner

EMOCOG Co., Ltd.

Attorney

James J. Saul

Filing Date

Jan 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

VOIXNOSIS Trademark

Serial Number: 97743897 • Registration: 7637570

VOIXNOSIS is a trademark filed by EMOCOG Co., Ltd. on January 6, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

EMOCOG Co., Ltd. (6 trademarks)

#404, 117, Sillim-ro,

Entity Type: 03

Trademark Details

Filing Date

January 6, 2023

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Downloadable and recorded computer software for the diagnosis of brain diseases; Downloadable and recorded computer software for use in testing in the field of brain diseases; Downloadable and recorded computer software for use in the field of neuropsychological testing; Downloadable and recorded computer operating system software; Recorded and downloadable electronic data files featuring information related to cognitive diseases and disorders; Downloadable multimedia file containing information in the nature of artwork, audio, video, text related to cognitive diseases and disorders; Downloadable and recorded computer software for the diagnosis of dementia; Downloadable and recorded computer software for use in testing for dementia; Downloadable and recorded computer software for use in testing for diseases and disorders; Downloadable and recorded computer software for diagnosing medical diseases and disorders; Downloadable and recorded computer software for use with medical apparatus and instruments; Downloadable and recorded computer software for early diagnosis and identification of dementia; Downloadable and recorded software for speech and voice recognition; Downloadable and recorded speech and voice recognition software using artificial intelligence; Electronic downloadable publications, namely, books, magazines, manuals for use by medical professionals in the field of science and medicine; Data collection apparatus for medical use in the nature of a data processing apparatus; Downloadable and recorded data processing software; Medical data transmission network routers; Diagnostic apparatus, namely, medical laboratory research measuring instruments for analyzing blood, body fluid, tissue or other biological samples not for medical purposes; Diagnostic apparatus in the nature of medical laboratory research instruments for non-medical purposes, namely, imaging machines for the diagnosis of cognitive disorders

Medical information services, namely, providing information relating to treatment of brain disease; Medical information services, namely, providing information relating to screening tests for dementia; Medical diagnostic services in the nature of medical testing for diagnostic purposes, using speech and voice recognition software with artificial intelligence; Medical examinations provided by use of automatic response software; Health care; Health counselling; Physical examination services; Providing healthcare services, namely, psychological therapy; Provision of psychological treatment; Consultancy relating to pharmaceutical and medical products for medical treatment use; Medical and health care services, namely, behavioral and mental health services; Medical examination services; Medical and surgical diagnostic services in the nature of medical testing for diagnostic and surgical purposes; Psychological testing for medical purposes; Medical information; Medical diagnostic services in the nature of medical testing for diagnostic purposes; Medical information services provided via the Internet; Mental health services; Medical diagnostic services in the nature of medical testing for diagnostic purposes, relating to brain disease

Telemetry apparatus for medical purposes; Medical instruments for diagnosing dementia which use speech and voice recognition software with artificial intelligence; Medical instruments for use in diagnosing of cognitive disorders using automatic response system; Medical apparatus and instruments for use in diagnosing of dementia using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosing of dementia using automatic response system; Telemetry apparatus for medical purposes, namely, telemetry devices relating to the diagnosis of dementia, Parkinson's disease and depressive disorder; Medical diagnostic instruments having automatic response function for monitoring and analyzing brain function; Medical diagnostic instruments having automatic response function for diagnosis and treatment of Mild Cognitive Impairment; Medical diagnostic instruments having automatic response function for the diagnosis of dementia and cognitive disorders; Medical diagnostic instruments having speech and voice recognition function for monitoring and analyzing brain function; Medical diagnostic instruments having speech and voice recognition function for diagnosis and treatment of Mild Cognitive Impairment; Medical diagnostic instruments having speech and voice recognition function for the diagnosis of dementia and cognitive disorders; Medical diagnostic and testing apparatus and instruments for diagnosing brain diseases, namely, neurodegenerative disease, cognitive disorders and mental illness in human beings; Medical diagnostic apparatus and instruments for use in diagnosis and treatment of cognitive disorders and neurological disorders; Diagnostic measuring apparatus for medical use for measuring neurophysiological signals; Medical apparatus and instruments in the field of clinical diagnosis, namely, apparatuses for analyzing brain wave frequencies and electroencephalographs; Medical apparatus and instruments in the fields of clinical diagnosis, namely, instruments for monitoring oxymetory, gas, analysis, and vital signs; Medical apparatus and instruments in the fields of clinical diagnosis, namely, biopsy instruments, and biopsy needles; Medical diagnostic apparatus for testing neurodegenerative conditions of the brain; Trace material analyzers for medical diagnostic uses; Test equipment for medical use, namely, medical diagnostic apparatus for testing body fluid samples; Medical apparatus and instruments for use in diagnosing of depressive disorders using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosing of Parkinson's disease using speech and voice recognition software with artificial intelligence; Medical apparatus and instruments for use in diagnosis and treatment of cognitive disorders and neurological disorders; Medical apparatus and instruments for use in diagnosis and treatment of dementia; Medical apparatus and instruments for use in diagnosis and treatment of neurodegenerative disease; Medical apparatus and instruments for use in diagnosis and treatment of Mild Cognitive Impairment

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 3, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 3, 2024 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 3, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 3, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 3, 2024 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 9, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 9, 2024 CRFA
ASSIGNED TO LIE
Oct 9, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jun 24, 2024 ERSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 25, 2024 RCCK
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 25, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 25, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 25, 2024 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 25, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 25, 2023 GNSL
SUSPENSION LETTER WRITTEN
Sep 25, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 15, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 15, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 15, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 15, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 15, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 15, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 30, 2023 NWOS
NEW APPLICATION ENTERED
Jan 10, 2023 NWAP